Preferred Creditor Status and African Multilateral Financial Institutions
Contemporary Issues in African Trade and Trade Finance · 01.12.2025 · 10 (2) · 62-77
DOI: 10.82529/ciat.10.2.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contemporary Issues in African Trade and Trade Finance, online erschienen am 01.12.2025. Verfasst von Amira El-Shal.
Abstract (Originalsprache)
Africa’s chronic development financing shortfall is exacerbated by volatile capital flows and discriminatory pricing in global debt markets, undermining growth, resilience, and inclusive development. This paper explores how Preferred Creditor Status (PCS) equips African Multilateral Financial Institutions (AMFIs) to address these challenges by providing: (1) a concessional financing window marked by narrower spreads, longer maturities, and tailored grace periods; and (2) strengthened countercyclical lending capacity through streamlined governance and rapid emergency liquidity deployment. Empirical evidence from Sub-Saharan Africa, where a 1.71 percent average annual sovereign default rate coincides with a 95.5 percent recovery rate, underscores robust post-default frameworks. The study evaluates the legal foundations and enforceability of PCS at key institutions and outlines four strategic policy pillars to enhance AMFIs’ concessional lending and crisis-response capabilities.
Zitieren
APA
El-Shal, A. (2025). Preferred Creditor Status and African Multilateral Financial Institutions. Contemporary Issues in African Trade and Trade Finance, 10(2), 62-77. https://doi.org/10.82529/ciat.10.2.004
Vancouver
El-Shal A. Preferred Creditor Status and African Multilateral Financial Institutions. Contemporary Issues in African Trade and Trade Finance. 2025;10(2):62-77. doi:10.82529/ciat.10.2.004
BibTeX
@article{ElShal2025,
author = {El-Shal, Amira},
title = {Preferred Creditor Status and African Multilateral Financial Institutions},
journal = {Contemporary Issues in African Trade and Trade Finance},
year = {2025},
volume = {10},
number = {2},
pages = {62--77},
doi = {10.82529/ciat.10.2.004}
}
EUVIMED